Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glycosylated hemoglobin A2 components

C Tegos, E Beutler

    Blood
    |September 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Glycosylated hemoglobin A2 components were detected, similar to hemoglobin A1 derivatives. These findings were confirmed using radiolabeled glucose, and elevated levels were observed in diabetic patients, indicating potential diagnostic value.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    T24 h-ras gene-expression increases the activity of phosphoglycerate kinase, enolase and pyruvate-kinase and decreases the activity of adenosine-deaminase in fibroblast cells.

    Oncology reports·2011
    Same author

    Molecular heterogeneity of the glucose-6-phosphate dehydrogenase deficiency in the Hellenic population.

    Human heredity·2000
    Same author

    1342C mutation in Gaucher's disease.

    Lancet (London, England)·1995
    Same author

    Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.

    American journal of hematology·1995
    Same author

    Gaucher disease.

    Medicine·1995
    Same author

    Treatment regimens in Gaucher's disease.

    Lancet (London, England)·1995

    Area of Science:

    • Biochemistry
    • Analytical Chemistry
    • Clinical Chemistry

    Background:

    • Hemoglobin variants play crucial roles in oxygen transport and disease diagnostics.
    • Glycosylation of hemoglobin is a key indicator in monitoring glycemic control, particularly for hemoglobin A1c.
    • The glycosylation status of hemoglobin A2 (HbA2) has been less characterized compared to hemoglobin A (HbA).

    Purpose of the Study:

    • To investigate the presence and characteristics of glycosylated components in partially purified hemoglobin A2.
    • To determine if these glycosylated HbA2 components exhibit similar properties to known glycohemoglobin derivatives of HbA.
    • To assess the levels of glycosylated HbA2 in individuals with diabetes mellitus.

    Main Methods:

    • Isoelectric focusing (IEF) was employed to separate and analyze hemoglobin components based on their isoelectric points.

    Related Experiment Videos

  • Acid agar gel electrophoresis was utilized as a complementary technique for analyzing hemoglobin fractions.
  • Radiolabeling with 14C-glucose was performed to confirm the binding of glucose to HbA2 and its association with specific bands.

    • Main Results:

    • Minor bands analogous to the glycohemoglobin derivatives of hemoglobin A (HbA1a, HbA1b, HbA1c) were detected in HbA2 preparations.
    • Experimental evidence confirmed that 14C-glucose bound to HbA2 co-migrated with these minor bands, identifying them as glycohemoglobins.
    • Elevated levels of glycosylated HbA2 derivatives were observed in the blood samples of diabetic patients compared to non-diabetic individuals.

    Conclusions:

    • Partially purified hemoglobin A2 contains glycosylated components, analogous to those found in hemoglobin A.
    • The presence and increased levels of glycosylated HbA2 in diabetic patients suggest its potential as a biomarker for glycemic control.
    • Further research into glycosylated HbA2 may offer complementary or alternative diagnostic information in diabetes management.